|
STATEMENT OF HDMA PRESIDENT AND CEO JOHN M. GRAY ON THE CENTERS FOR MEDICARE & MEDICAID SERVICES' PROPOSED AMP IMPLEMENTATION RULE
ARLINGTON, Va., January 27, 2012 – John M. Gray, President and CEO of the Healthcare Distribution Management Association (HDMA), released the following statement on The Centers for Medicare & Medicaid Services’ (CMS) new proposed rule clarifying the implementation of changes to the calculation of average manufacturer price (AMP) established by the Patient Protection and Affordable Care Act (PPACA):
“We are pleased that CMS has released this long-awaited draft AMP guidance for the industry. The 2010 healthcare reform legislation included changes to the AMP reimbursement methodology that had significant implications for the healthcare supply chain. Prior to full implementation, HDMA has sought clarification on a host of issues ranging from the treatment of bona fide services to government expectations for documenting fair market value. Our hope is that this proposed guidance provides the clarity the industry has been seeking.
In the coming weeks HDMA, with our members, will review the proposed rule and provide further comments to CMS within the 60-day time frame. We look forward to continued collaboration across government and industry to accurately navigate the requirements and expectations of the new AMP guidance.”
About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that nearly nine million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, nursing homes, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation’s healthcare system an estimated $32 billion per year. |
